Skip to content
Blerp – Lifestyle
Author:
Scancell Holdings plc
Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development
September 24, 2026
Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
July 23, 2026